New partnership with RESPINOR

16/02/2026 10:39 AM - Comment(s) - By Andrew Finnie

Pioneering diaphragm monitoring now available

Eden Medical is delighted to announce a new distribution partnership with RESPINOR, bringing their innovative diaphragm monitoring technology to clinicians in critical care settings.

DXT, or Diaphragm Excursion Technology, is a groundbreaking non-invasive medical device developed by RESPINOR that utilizes ultrasound for operator-independent, continuous monitoring of the diaphragm, the main breathing muscle, in critically ill patients.

RESPINOR DXT® offers a non‑invasive, real‑time way to monitor diaphragm movement—supporting better decision‑making in critical care and helping improve patient outcomes. 

We’re excited to work with RESPINOR as they expand their presence in the UK.

Andrew Finnie

Share -